Last updated on May 2018

EARLY Trial - A Clinical Trial for Those at Risk of Developing Memory Loss Due to Alzheimer's disease

Brief description of study

The purpose of this study is to evaluate whether the investigational medication, JNJ-54861911, slows cognitive decline compared with placebo (inactive treatment) in individuals with generally normal memory and thinking ability but who are at risk for developing Alzheimer's dementia.  Study qualification and whether or not a potential study participant is considered at risk will be determined by the research center as part of the study procedures. 

This is a global long term study with the goal of including 1650 participants worldwide. After the screening period, qualified study participants will visit the research center up to 26 times over up to 54 months.

Clinical Study Identifier: TX155545

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.